Lampire Biological Laboratories continues to lead neighboring Bedford County and the entire I-99 Corridor counties (Bedford, Blair, and Centre) into the exciting field of biotechnology.

The company is in the process of expanding its Everett facility’s manufacturing capacity to meet the needs of a $5.5 million contract that is scheduled to be completed over the next five years.

“We have a new contract from a Fortune 50, international pharmaceutical company,” said Gregory Krug, president and CEO at Lampire. “We will be doing a specialized tissue processing, preparing the tissue for a special extraction.” Lampire Biological Labs has been named as one of Pennsylvania's top companies in workforce development and has established numerous relationships with Penn State researchers.

The extraction itself will be done by the pharmaceutical company, Krug explained. The resulting material will be an injectable product that will aid in the treatment of arthritis.

“We are not expanding our facility. Instead we are renovating internal space and giving our staff an additional 3,000 to 4,000 square feet of manufacturing space,” said Krug.

The new contract required the purchase of specialized equipment and water systems costing $900,000.

Krug and Lampire are leaders in the burgeoning field of biotechnology, creating products that are saving lives across the nation and world.